Successful use of methylprednisolone for treating severe COVID-19.
-
Authors
-
-
Liu, Jing1
-
Zheng, Xiaobin2
-
Huang, Yiying2
-
Shan, Hong3
-
Huang, Jin4
-
1
Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
,
(China)
-
2
Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
,
(China)
-
3
Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China; Department of Radiology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. Electronic address: [email protected]
,
(China)
-
4
Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. Electronic address: [email protected]
,
(China)
- Type
- Published Article
- Journal
-
The Journal of allergy and clinical immunology
- Publication Date
-
Aug 01, 2020
- Volume
-
146
- Issue
-
2
- Pages
-
325–327
- Identifiers
-
DOI: 10.1016/j.jaci.2020.05.021
-
PMID: 32479759
- Source
-
Medline
- Language
-
English
- License
-
Unknown
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 01/04/2021 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/32479759
